CardioLogs ECG Analysis Platform vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Imbio

AI Verdict

While both tools leverage AI in cardiology, they address distinct diagnostic needs and utilize different data modalities. Tool A focuses on analyzing ECG data for arrhythmia detection, making it suitable for rhythm disorder diagnostics. Tool B, conversely, processes CTPA scans to measure ventricular dimensions for risk stratification in pulmonary conditions, appealing to structural cardiac assessment in a different clinical context.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is a highly accurate, AI-driven solution for the rapid and efficient analysis of diverse ECG data, including from Holter monitors, smartwatches, and ECG patches. This platform is ideal for cardiologists and clinicians focused on detecting and diagnosing various arrhythmias across a broad spectrum of patient monitoring scenarios.

View CardioLogs ECG Analysis Platform →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if you require an automated, AI-powered tool to precisely measure right and left ventricular diameters from CTPA scans. This solution is best suited for radiologists and cardiologists who need to quickly calculate RV/LV ratios to aid in the risk stratification of patients presenting with pulmonary conditions, such as suspected pulmonary embolism.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Imbio RV/LV Software
Deployment Cloud-based Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio RV/LV Software

While both tools aim for automation and seamless integration, Imbio RV/LV Software explicitly highlights a 'fully automated workflow, no user intervention required after scan completion' for its core function. This suggests a more hands-off and streamlined experience for the end-user once integrated into their PACS, minimizing manual steps.

Clinical Value

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform offers broad clinical value in arrhythmia detection across various ECG devices, including smartwatches, and is the first FDA-cleared AI solution for ECG analysis. Its extensive clinical validation demonstrates significant improvements, such as a 10x reduction in AF false positives and a 42% decrease in analysis duration.

Pricing & Value

Tie

Both tools employ opaque pricing models that necessitate direct contact with sales for a customized quote, making a direct comparison of their value difficult. Both utilize common enterprise pricing structures, with CardioLogs offering a 'pay per ECG' model and Imbio a 'subscription-based' model tied to analyses or installations.

Enterprise Readiness

Imbio RV/LV Software

Imbio RV/LV Software demonstrates superior enterprise readiness through its highly flexible deployment options, which include cloud, on-premise, and integration with numerous partner platforms. This versatility caters to diverse IT infrastructures and preferences within large healthcare organizations, further bolstered by explicit third-party HIPAA certification.

Innovation

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform exhibits broader innovation by applying deep neural networks to a wide array of ECG data sources, including consumer smartwatches, and was the first AI solution approved by the FDA for ECG analysis in 2017. Its tagline 'Reinventing cardiology diagnostics' reflects a more transformative approach to the field.

Support & Docs

Imbio RV/LV Software

Imbio RV/LV Software offers a more explicitly comprehensive and transparent support structure, including 24/7/365 monitoring for email and website support tickets, multiple dedicated phone lines with clear hours, and a structured online case submission system. This level of detail and availability suggests a stronger commitment to customer support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Imbio RV/LV Software
Primary Function Rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. Automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Company Cardiologs Technologies (now part of Philips) Imbio
Input Data Type ECG data from various cardiac monitoring devices (Holter, smartwatches, ECG patches) CTPA scans
Key Output/Measurement Automated Arrhythmia Detection (e.g., AFib, VT), Customizable Reports Automated measurement of right and left ventricular diameters, Calculation and reporting of RV/LV ratio, Annotated images showing ventricular measurements, Summary PDF reports.
Integration Integration with EHR Systems Integration with standard reading environments (PACS)

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Imbio RV/LV Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform uses medical-grade AI to analyze ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. Imbio RV/LV Software is an AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans to provide a ratio for risk stratification in pulmonary conditions like pulmonary embolism.
CardioLogs ECG Analysis Platform uses a 'pay per ECG' model, irrespective of the number of users. Imbio RV/LV Software is subscription-based, with pricing determined by the number of analyses or installations.
CardioLogs ECG Analysis Platform provides AI-powered ECG analysis for automated arrhythmia detection and customizable reports. Imbio RV/LV Software calculates and reports the RV/LV ratio, provides annotated images showing ventricular measurements, and generates summary PDF reports.
CardioLogs ECG Analysis Platform offers integration with EHR systems. Imbio RV/LV Software is DICOM compliant for input and output and integrates with standard reading environments like PACS.
AI Tool Finder
AI-powered search. Results may not be comprehensive.